Clinical Trial Update: First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients [Phase 1, Phase 2]

View source ↗

Summary

First-in-human Phase 1/2 study of ABD-3001 to evaluate safety, tolerability, pharmacokinetics, and preliminary activity in adults with refractory or relapsed ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• ABD-3001

Snippet

Sponsor: Advanced BioDesign | Conditions: Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: RECRUITING